Everolimus-Eluting Stent and Dedicated 2-Stent Strategy in Complex 'True' Bifurcation Lesion with Major Side Branch Involvement

被引：0
|
作者：
Kherada, Nisharahmed I. [1 ]
Mennuni, Marco G. [2 ]
Meelu, Omar A. [3 ]
Sartori, Samantha [4 ]
Baber, Usman [4 ]
Sayeneni, Swapna [1 ]
Roy, Swathi [1 ]
Walker, Linsey [3 ]
Mohanty, Bibhu D. [5 ]
Tomey, Matthew [6 ]
Looser, Patrick [4 ]
Moreno, Pedro R. [1 ]
Krishnan, Prakash [4 ]
Kovacic, Jason [1 ]
Pyo, Robert T. [1 ]
Sweeny, Joe [4 ]
Dangas, George [7 ]
Mehran, Roxana [6 ]
Sharma, Samin [4 ]
Kini, Annapoorna [8 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Ist Clin Humanitas, Milan, Italy
[3] Icahn Sch Med Mt Sinai, New York, NY USA
[4] Mt Sinai Sch Med, New York, NY USA
[5] Mt Sinai Heart, New York, NY USA
[6] Mt Sinai Hosp, New York, NY 10029 USA
[7] Mt Sinai, New York, NY USA
[8] Mt Sinai Med Ctr, Cardiovasc Inst, New York, NY 10029 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 62卷 / 18期
关键词：
D O I：
10.1016/j.jacc.2013.08.1140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B125 / B125
页数：1
相关论文
共 50 条
  • [31] Strategy for optimal side-branch positioning of bioresorbable vascular scaffolds in dedicated 2-stent techniques: Insights from optical coherence tomography
    Miyazaki, Tadashi
    Costopoulos, Charis
    Sato, Katsumasa
    Naganuma, Toru
    Panoulas, Vasileios F.
    Figini, Filippo
    Latib, Azeem
    Colombo, Antonio
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2014, 15 (05) : 298 - 300
  • [32] Impact of stent overlap on 2-year clinical outcomes in patients treated with biolimus-eluting stent and cobalt chromium everolimus-eluting stent
    Hiromasa, T.
    Kuramitsu, S.
    Jinnouchi, H.
    Morinaga, T.
    Kobayashi, Y.
    Domei, T.
    Hyodo, M.
    Soga, Y.
    Shirai, S.
    Ando, K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 482 - 482
  • [33] 3-year clinical follow-up of the PYTON (Prospective Evaluation of the TRYTON Side-Branch Stent™with an additional XIENCE-V™ Everolimus-Eluting Stent in Coronary Bifurcation Lesions) study
    Bennett, Lohan
    Adriaenssens, Tom
    Sinnaeve, Peter
    Ferdinande, Bert
    Desmet, Walter
    De Cock, Dries
    Coosemans, Mark
    Dubois, Christophe
    ACTA CARDIOLOGICA, 2014, 69 (01) : 80 - 80
  • [34] Long-term clinical outcomes of coronary bifurcation stenting with sirolimus-eluting versus everolimus-eluting stent
    Lee, H. J.
    Yu, C. W.
    Choi, R. K.
    Park, J. S.
    Jang, J. W.
    Li, H. U.
    Shim, W. H.
    EUROPEAN HEART JOURNAL, 2012, 33 : 388 - 389
  • [35] Midterm outcomes of 2-stent procedures with sirolimus-eluting stent in left main coronary artery bifurcation lesions
    Tazaki, J.
    Tada, T.
    Hanazawa, K.
    Saito, N.
    Tamura, T.
    Toma, M.
    Furukawa, Y.
    Kimura, T.
    Kita, T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 57C - 57C
  • [36] Modeling the Ideal 2-Stent Strategy in Coronary Bifurcation! Is There Light at the End of the Tunnel?
    Daggubati, Ramesh
    Sabouni, Mohammed Amr
    Rigatelli, Gianluca
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2021, 24 : 18 - 19
  • [37] Regular Drug Eluting Stent versus dedicated bifurcation paclitaxel eluting stent (BiOSS®) in coronary bifurcation treatment - POLBOS (POLish Bifurcation Optimal treatment Strategy) randomized study
    Gil, Robert
    Vassilev, Dobrin
    Bil, Jacek
    Kern, Adam
    Formuszewicz, Radoslaw
    Dobrzycki, Slawomir
    Ungi, Imre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B199 - B199
  • [38] High disturbed flow in stent-implanted region predicts target lesion revascularization after everolimus-eluting stent implantation in hemodialysis
    Osaka, Y.
    Hikita, H.
    Kawaguchi, N.
    Akiyama, D.
    Sugiyama, T.
    Kimura, S.
    Takahashi, A.
    Isobe, M.
    EUROPEAN HEART JOURNAL, 2013, 34 : 228 - 229
  • [39] β-Blockers Reduced the Target Lesion Revascularization After Percutaneous Coronary Intervention Using an Everolimus-eluting Stent
    Fujinami, Tatsuya
    Ashikaga, Takashi
    Hoshina, Katsuyuki
    Sasaoka, Taro
    Kurihara, Ken
    Yoshikawa, Shunji
    Inagaki, Hiroshi
    Sasano, Tetsuo
    IN VIVO, 2022, 36 (01): : 416 - 423
  • [40] 5-Year Clinical Follow-up of the PYTON (Prospective Evaluation of the TRYTON Side-Branch Stent with an additional XIENCE-V Everolimus-Eluting Stent in Coronary Bifurcation Lesions) Study.
    Bennett, Johan
    Hiltrop, Nick
    Adriaenssens, Tom
    Sinnaeve, Peter
    Desmet, Walter
    Dubois, Christophe
    ACTA CARDIOLOGICA, 2016, 71 (01) : 101 - 101
12345